12.01.2009 12:00:00

Henry Schein to Present at the 27th Annual JP Morgan Healthcare Conference

Henry Schein, Inc., (Nasdaq: HSIC), the largest provider of healthcare products and services to office-based practitioners in the combined North American and European markets, announced today that Stanley M. Bergman, Henry Schein’s Chairman and Chief Executive Officer, and Steven Paladino, the Company’s Executive Vice President and Chief Financial Officer, will present at the 27th Annual JP Morgan Healthcare Conference on Tuesday, January 13, 2009. The Conference is being held at The Westin St. Francis Hotel in San Francisco, Calif.

Henry Schein’s presentation will begin at 5 p.m. EST. It can be heard via live webcast by visiting www.henryschein.com, clicking on "Investor Relations” and following the link for "Webcasts.” A replay will be available on the web site following the presentation.

About Henry Schein

Henry Schein, a Fortune 500® company and a member of the Nasdaq 100® Index, is recognized for its excellent customer service and highly competitive prices. The Company’s four business groups – Dental, Medical, International and Technology – serve more than 550,000 customers worldwide, including dental practitioners and laboratories, physician practices and animal health clinics, as well as government and other institutions. The Company operates through a centralized and automated distribution network, which provides customers in more than 200 countries with a comprehensive selection of more than 90,000 national and Henry Schein private-brand products in stock, as well as more than 100,000 additional products available as special-order items.

Henry Schein also offers a wide range of innovative value-added practice solutions for healthcare professionals, such as ArubA®, the Company’s electronic catalog and ordering system. Its leading practice-management software solutions have an installed user base of more than 52,000 practices, including DENTRIX®, Easy Dental®, Oasis® and EXACT® for dental practices, MicroMD® for physician practices, and AVImark® for animal health clinics. Headquartered in Melville, N.Y., Henry Schein employs over 12,000 people and has operations or affiliates in 20 countries. The Company’s net sales reached a record $5.9 billion in 2007. For more information, visit the Henry Schein Web site at www.henryschein.com.

JETZT DEVISEN-CFDS MIT BIS ZU HEBEL 30 HANDELN
Handeln Sie Devisen-CFDs mit kleinen Spreads. Mit nur 100 € können Sie mit der Wirkung von 3.000 Euro Kapital handeln.
82% der Kleinanlegerkonten verlieren Geld beim CFD-Handel mit diesem Anbieter. Sie sollten überlegen, ob Sie es sich leisten können, das hohe Risiko einzugehen, Ihr Geld zu verlieren.

Analysen zu Henry Schein Inc.mehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel

Henry Schein Inc. 68,56 -0,81% Henry Schein Inc.

Indizes in diesem Artikel

NASDAQ Comp. 19 478,88 -0,06%
NASDAQ 100 21 180,96 0,04%